CRESEMBA QUICK START+® Program
The CRESEMBA QUICK START+® Program provides a one-time, 7-day supply of CRESEMBA® (isavuconazonium sulfate) capsules at no cost to new adult patients who experience a delay in insurance coverage.
- Patient eligibility for this program includes:
- Be new to CRESEMBA therapy
- Have experienced an insurance-related access delay
- Have been prescribed CRESEMBA for an FDA-approved indication
- Allows patients to start their CRESEMBA treatment while CRESEMBA Support Solutionsa works with the patient's insurer to resolve coverage issues
- Offers overnight shipping directly to the patient
a CRESEMBA Support Solutions is a component of Astellas Pharma Support SolutionsSM.
QUICK START+® is a registered trademark of Astellas US LLC.